(Q48204825)

9 February 2018

title

Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study (English)

1 reference

9 February 2018

amyotrophic lateral sclerosis

main subject

0 references

2

Albert C Ludolph

1 reference

9 February 2018

Alexander Unrath

1

1 reference

9 February 2018

Jan Kassubek

series ordinal

3

1 reference

9 February 2018

publication date

13 April 2007

1 reference

9 February 2018

published in

Journal of Neurology

1 reference

9 February 2018

volume

254

1 reference

9 February 2018

issue

8

1 reference

9 February 2018

page(s)

1099-1106

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s00415-006-0495-2

exact match

0 references

cites work

Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-0495-2

Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-0495-2

A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-0495-2

Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-0495-2

Proton MR spectroscopy in succinic semialdehyde dehydrogenase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-0495-2

1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-0495-2

Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy

21 January 2018

1 reference

12 December 2020

ALS surrogate markers. MRS.

1 reference

12 December 2020

Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements.

1 reference

12 December 2020

Locating the central sulcus: comparison of MR anatomic and magnetoencephalographic functional methods.

1 reference

12 December 2020

MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis.

1 reference

12 December 2020

Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study

1 reference

12 December 2020

Brain and spinal cord MRI in motor neuron disease

1 reference

12 December 2020

The corticospinal tract in amyotrophic lateral sclerosis: an MRI study.

1 reference

12 December 2020

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

1 reference

12 December 2020

Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron

1 reference

12 December 2020

In vivo proton spectroscopy in presence of eddy currents

1 reference

12 December 2020

Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis)

1 reference

12 December 2020

Imaging and neurochemical markers for diagnosis and disease progression in ALS.

1 reference

12 December 2020

Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy.

1 reference

12 December 2020

A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline

1 reference

12 December 2020

Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI.

1 reference

12 December 2020

Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo

1 reference

12 December 2020

Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types.

1 reference

12 December 2020

Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings

1 reference

12 December 2020

The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group

1 reference

12 December 2020

Magnetic resonance imaging in amyotrophic lateral sclerosis

1 reference

12 December 2020

Magnetic resonance imaging of the corticospinal tracts in amyotrophic lateral sclerosis

1 reference

12 December 2020

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

12 December 2020

Review neuroimaging in amyotrophic lateral sclerosis

1 reference

12 December 2020

High signal intensity on T1 weighted MRI of the anterolateral column of the spinal cord in amyotrophic lateral sclerosis

1 reference

12 December 2020

10.1007/S00415-006-0495-2

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018